12 Questions
What is the primary benefit of a combination of IV iron and erythropoiesis-stimulating agents (ESAs) for chronic kidney disease patients?
Reduction in the required dose of ESAs
Why is high-dose IV iron therapy not recommended for chronic kidney disease patients?
Concerns over iron toxicity and oxidative stress
What limits the efficacy and tolerability of oral iron therapy in patients with chronic diseases?
Specific inflammatory condition at the site of inhibition of erythropoiesis
Why is a combination of erythropoiesis-stimulating agents (ESAs) and IV iron therapy more appropriate in certain cases?
It avoids functional iron deficiency and accumulation in the reticuloendothelial system
How does erythropoiesis-stimulating agents (ESAs) affect iron requirements in the body?
Increases iron requirements
Why is oral iron considered the frontline treatment for Iron Deficiency Anemia (IDA)?
It can bypass the inflammatory condition in chronic diseases
What was the result of administering iron and ascorbic acid to normal volunteers in a study?
Significant increases in hemoglobin, hematocrit, and serum iron concentration
In what cases is the heme oxygenase inhibitor SnMP particularly useful when used with iron?
In cases where oral iron has failed
What is the preferred form of iron therapy according to the 2008 NICE guidelines?
Parenteral iron therapy
Why may treatment with oral iron alone be ineffective and potentially detrimental in cases associated with chronic inflammatory states or infection?
It generates oxygen-free radicals from iron loading of the reticuloendothelial system
What do recent large randomized controlled trials suggest about the most effective regimens for iron replacement therapy?
Combining oral and parenteral iron is the most effective
What is the purpose of initially giving oral iron for a few weeks followed by parenteral iron in anemic patients?
To assess and improve hemoglobin response if inadequate
Learn about the benefits of combining IV iron and erythropoiesis-stimulating agents (ESAs) for Chronic Kidney Disease patients with iron deficiency anemia. Understand how this approach can lead to higher hemoglobin levels, reduced ESA doses, and less rapid decline in renal function compared to standard care with oral iron.
Make Your Own Quizzes and Flashcards
Convert your notes into interactive study material.
Get started for free
